Delphia Therapeutics Revenue and Competitors

Cambridge, MA USA

Location

N/A

Total Funding

Biotech

Industry

Employee Data

  • Delphia Therapeutics has 24 Employees.(i)
  • Delphia Therapeutics grew their employee count by 26% last year.

Delphia Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
N/A1110%N/AN/A
#10
$5.4M353%N/AN/A
Add Company

What Is Delphia Therapeutics?

Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.

keywords:N/A

N/A

Total Funding

24

Number of Employees

N/A

Revenue (est)

26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$89.3M24-54%N/A
#2
$2.4M24N/AN/A
#3
$3.8M2441%N/A
#4
$3.7M24-38%N/A
#5
$3.5M249%N/A